Avidity Biosciences, Inc. (RNA)

Avidity Biosciences Stock Forecast

Stock Price Forecast

The 19 analysts that cover Avidity Biosciences stock have a consensus rating of "Buy" and an average price target of $69.26, which forecasts a -3.62% decrease in the stock price over the next year. The lowest target is $55 and the highest is $96.

Price Target: $69.26 (-3.62%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$55	$69.26	$72	$96
Change	-23.46%	-3.62%	+0.19%	+33.59%

* Price targets were last updated on Nov 11, 2025.

Analyst Ratings

The average analyst rating for Avidity Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	7	7	9	4	4	4
Buy	7	8	8	7	7	7
Hold	0	0	0	9	9	9
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	15	17	20	20	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Keay Nakae Chardan Capital	Chardan Capital	Hold Maintains $72	Hold	Maintains	$72	+0.19%	Nov 11, 2025
Ritu Baral TD Cowen	TD Cowen	Strong Buy → Hold Downgrades $78 → $74	Strong Buy → Hold	Downgrades	$78 → $74	+2.98%	Oct 29, 2025
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy → Hold Downgrades $75 → $72	Strong Buy → Hold	Downgrades	$75 → $72	+0.19%	Oct 28, 2025
Luca Issi RBC Capital	RBC Capital	Buy → Hold Downgrades $61 → $72	Buy → Hold	Downgrades	$61 → $72	+0.19%	Oct 28, 2025
Geoff Meacham Citigroup	Citigroup	Strong Buy → Hold Downgrades $75 → $72	Strong Buy → Hold	Downgrades	$75 → $72	+0.19%	Oct 27, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

17.88M

Increased by 64.11%

from 10.90M

Revenue Next Year

24.54M

Increased by 37.25%

from 17.88M

EPS This Year

-4.61

from -2.89

EPS Next Year

-5.36

from -4.61

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	6.79M	9.33M	9.22M	9.56M	10.90M	17.88M	24.54M
Revenue Growth	192.67%	37.41%	-1.09%	3.64%	13.99%	64.11%	37.25%
EPS	-2.05	-2.85	-3.34	-2.91	-2.89	-4.61	-5.36
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	16	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	31.9M	68.7M
Avg	17.9M	24.5M
Low	5.3M	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	192.9%	284.0%
Avg	64.1%	37.2%
Low	-51.4%	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-4.10	-4.45
Avg	-4.61	-5.36
Low	-4.71	-6.40

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.